TOP｜ 特許｜ 意匠｜ 商標
商標ウォッチ Twitter
公開日2024-12-04
公報種別公開国際商標公報
国際登録番号1812649
国際登録日2024-08-23
区分第5類(薬剤),第42類(科学・技術)
商品役務Diagnostic biomarker reagents for medical and clinical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; biomarker assays to identify disease activity; biomarker assays to quantify disease activity; biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; diagnostic preparations, substances and materials; medical diagnostic test strips; diagnostic preparations for medical purposes; diagnostic agents for medical use.,Design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; design and development of biochemical, pharmaceutical, and medical assays; design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; identification of predictive and prognostic biomarkers for clinical trials; identifing patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; clinical trials; analysis of pharmacodynamic data; analysis of data relating to biomarkers; development of diagnostic preparations, equipment and tests; clinical testing services; diagnostic testing services; testing services relating to the detection and measurement of biomarkers; testing samples for the presence of biomarkers; laboratory services; medical laboratory services; research laboratory services; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research全 22 件を表示, experimentation, development, and analysis; advice, information and assistance relating to the foregoing.
基礎出願番号019002624
基礎出願日2024-03-21
基礎出願国EM
出願人Nordic Bioscience A/S
OCRテキストnordicEndotrophin
OCRテキスト2nordicEndotrophin
OCRについて
この商標をJ-PlatPatで参照する

関連商標

DAM Group UK International Limited
8 .***Dr.Frank's WeightLossClinic
1か月前
NUTRITIONAL WHOLESOME BLENDS PTY LTD
Blended. BYSARAH
1か月前
Novo Nordisk A/S
Zilconyc
5か月前
Biohaven Therapeutics Ltd.
1か月前
ZEALAND PHARMA A/S
22日前
Biohaven Therapeutics Ltd.
REJUTRIA
29日前
Made By Brave Limited
ANCIENT+BRAVE
22日前
LESAFFRE ET COMPAGNIE
22日前
Made By Brave Limited
1か月前
Aston Group Worldwide Ltd
INESSA
22日前
Harbin Fuerjia Technology Co., Ltd.
Voolga
22日前
NUTRAVALIA
LUXEOL
4か月前
MAFRA GROUP S.r.l.
MANIAC LINE
22日前
TOBEFIVE Co., Ltd.
MOKITO
3か月前
PROTOX Inc.
1か月前
SANOFI BIOTECHNOLOGY
XALTYRZA
6か月前
個人
POLISHETTE
3か月前
Pure Sport Oil Ltd
3か月前
Instylla, Inc.
3か月前
Ionis Pharmaceuticals, Inc.
3か月前
Pure Salmon France SAS
3か月前
Immunocore Limited
3か月前
Hermes Arzneimittel GmbH
Biolectra MAGNESIUM
3か月前
Glanbia Nutritionals Limited
IMMU-PRIME
5か月前
BrainChild Bio, Inc.
BRAINCHILDBIO
6か月前
BEBIG Medical GmbH
3か月前
Incyte Holdings Corporation
4か月前
Zhejiang Shiyuer Industrial Co., Ltd.
1か月前
ZEALAND PHARMA A/S
3か月前
ZEALAND PHARMA A/S
3か月前
Magnum Worldwide Holdings Inc.
1か月前
Alchemab Therapeutics Ltd
ALCHEMAB
6か月前
Maui Molecular, LLC
3か月前
Novartis AG
EZDULIV
6か月前
Novartis AG
EMREZOY
6か月前
Novartis AG
EKPLORIQ
6か月前
続きを見る